Actively Recruiting

All Genders
NCT06566898

Monitoring of Antimicrobial Resistance Based on Metagenomics Analyses in Pneumonia Patients

Led by Shanghai General Hospital, China · Updated on 2026-04-23

800

Participants Needed

1

Research Sites

112 weeks

Total Duration

On this page

Sponsors

S

Shanghai General Hospital, China

Lead Sponsor

W

Wuxi People's Hospital Affiliated to Nanjing Medical University

Collaborating Sponsor

AI-Summary

What this Trial Is About

Monitoring of antimicrobial resistance (AMR) based on metagenomics analyses in pneumonia patients is critical for optimizing clinical diagnosis and treatment and improving clinical prognosis. This study is designed to ask the following key questions: 1. What is the microbiome maps of patients with severe pneumonia and mild pneumonia ? 2. How many pathogen resistance genes are carrying in severe pneumonia and mild pneumonia ? 3. What is the genetic diversity of key pathogens detected in severe pneumonia and mild pneumonia during 2019-2025?

CONDITIONS

Official Title

Monitoring of Antimicrobial Resistance Based on Metagenomics Analyses in Pneumonia Patients

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients clinically diagnosed with severe or mild pneumonia according to ATS/IDSA guidelines for adults or BTS guidelines for children
  • Diagnosis based on meeting at least one major or three minor criteria as defined in these guidelines
  • Clinical examination performed with remaining biospecimens such as nasopharyngeal swabs, oropharyngeal swabs, bronchoalveolar lavage fluid, sputum, blood, hydrothorax, or lung tissue from microbiological testing
Not Eligible

You will not qualify if you...

  • Patients whose biological samples may be contaminated
  • Patients with alveolar lavage fluid or hydrothorax volume less than 200 microliters

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Mei Kang

Shanghai, Shanghai Municipality, China, 200080

Actively Recruiting

Loading map...

Research Team

M

Mei Kang, MPH

CONTACT

X

Xue Tian, Master

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Monitoring of Antimicrobial Resistance Based on Metagenomics Analyses in Pneumonia Patients | DecenTrialz